NO20060991L - Feksofenadinsammensetning og fremgangsmate til fremstilling - Google Patents

Feksofenadinsammensetning og fremgangsmate til fremstilling

Info

Publication number
NO20060991L
NO20060991L NO20060991A NO20060991A NO20060991L NO 20060991 L NO20060991 L NO 20060991L NO 20060991 A NO20060991 A NO 20060991A NO 20060991 A NO20060991 A NO 20060991A NO 20060991 L NO20060991 L NO 20060991L
Authority
NO
Norway
Prior art keywords
composition
pexophenadine
preparation
plasma
hexophenadine
Prior art date
Application number
NO20060991A
Other languages
English (en)
Norwegian (no)
Inventor
Indranil Nandi
Ashish Anilbhai Patel
Mohnsen Sadatrezael
Pablo Davila
Virendra Maheshappa Khanapure
Durendra Wasudeorao Durugkar
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO20060991L publication Critical patent/NO20060991L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20060991A 2003-07-31 2006-02-28 Feksofenadinsammensetning og fremgangsmate til fremstilling NO20060991L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/631,874 US20050065183A1 (en) 2003-07-31 2003-07-31 Fexofenadine composition and process for preparing
PCT/EP2004/008600 WO2005013987A1 (fr) 2003-07-31 2004-07-30 Composition de fexofenadine et procede de preparation correspondant

Publications (1)

Publication Number Publication Date
NO20060991L true NO20060991L (no) 2006-04-28

Family

ID=34135544

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060991A NO20060991L (no) 2003-07-31 2006-02-28 Feksofenadinsammensetning og fremgangsmate til fremstilling

Country Status (12)

Country Link
US (1) US20050065183A1 (fr)
EP (1) EP1651218A1 (fr)
JP (1) JP2007500682A (fr)
AR (1) AR045193A1 (fr)
AU (1) AU2004262914A1 (fr)
BR (1) BRPI0413186A (fr)
CR (1) CR8220A (fr)
EC (1) ECSP066327A (fr)
NO (1) NO20060991L (fr)
RU (1) RU2006105720A (fr)
WO (1) WO2005013987A1 (fr)
ZA (1) ZA200600519B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444456A1 (fr) * 2001-04-09 2002-10-17 Teva Pharmaceutical Industries Ltd. Polymorphes de chlorhydrate de fexofenadine
PL380887A1 (pl) 2003-12-29 2007-04-02 Sepracor Inc. Pirolowe i pirazolowe inhibitory DAAO
MXPA06012281A (es) * 2004-04-26 2007-07-18 Teva Pharma Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion.
EP1685106A2 (fr) * 2004-09-28 2006-08-02 Teva Pharmaceutical Industries, Inc. Forme de cristal de fexofenadine et ses processus de preparation
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
WO2007073389A1 (fr) * 2005-12-22 2007-06-28 Teva Pharmaceutical Industries Ltd. Formes de dosage solides comprimées comprenant des médicaments de faible solubilité et procédé servant à les fabriquer
EP1808163A1 (fr) * 2005-12-22 2007-07-18 Teva Pharmaceutical Industries Ltd. Formes galéniques solides comprimées avec des principes actifs de faible solubilité et leur procédé de fabrication
US20070148245A1 (en) * 2005-12-22 2007-06-28 Ilan Zalit Compressed solid dosage forms with drugs of low solubility and process for making the same
EP2037918A2 (fr) * 2006-05-15 2009-03-25 Acadia Pharmaceuticals Inc. Formules pharmaceutiques de pimavansérine
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
MX363549B (es) * 2010-09-21 2019-03-26 Intekrin Therapeutics Inc Star Composiciones farmacéuticas sólidas antidiabéticas.
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法
WO2013125350A1 (fr) * 2012-02-23 2013-08-29 フロイント産業株式会社 Excipient à compression directe permettant de désintégrer oralement un comprimé et procédé de production de celui-ci, et comprimé à désintégration orale
JP6184727B2 (ja) * 2013-04-15 2017-08-23 ロート製薬株式会社 医薬組成物
CA2979033A1 (fr) 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methodes de traitement de la steatose hepatique non alcoolique et/ou de la lipodystrophie
CN106137989A (zh) * 2016-07-20 2016-11-23 南通雅本化学有限公司 一种基于盐酸非索非那定的药物组合物
US11253508B2 (en) 2017-04-03 2022-02-22 Coherus Biosciences, Inc. PPARy agonist for treatment of progressive supranuclear palsy
JP6410895B2 (ja) * 2017-07-26 2018-10-24 ロート製薬株式会社 医薬組成物
WO2022123511A1 (fr) * 2020-12-11 2022-06-16 Cellix Bio Private Limited Composition comprenant de la fexofénadine
GB202212656D0 (en) 2022-08-31 2022-10-12 Novumgen Ltd An orodispersible tablet of fecofenadine and it process of preparation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
JPS52151717A (en) * 1976-06-09 1977-12-16 Shionogi & Co Ltd Sugar coating on solid preparations
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
JPS6183123A (ja) * 1984-09-28 1986-04-26 Taisho Pharmaceut Co Ltd 抗喘息剤
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
DE69320952T2 (de) * 1992-05-11 1999-05-27 Merrell Pharma Inc Verwendung von terfenadin-derivaten als antihistaminika in leberkranken patienten
WO1995000482A1 (fr) * 1993-06-24 1995-01-05 Albany Molecular Research, Inc. Derives de piperidine et procedes de production de ces derives
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharma Inc Arzneizubereitungen für piperidinalkanolderivate
US6576636B2 (en) * 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
JPH09315971A (ja) * 1996-05-28 1997-12-09 Daito Kk テルフェナジン含有錠剤製剤
WO1998022105A1 (fr) * 1996-11-15 1998-05-28 Ajinomoto Co., Inc. Preparation en comprimes
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
WO2000038650A1 (fr) * 1998-12-23 2000-07-06 Alza Corporation Forme posologique a retention gastrique possedant des couches multiples
EP1054019A1 (fr) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Hydroxypropylcellulose possédant un faible degré de substitution
US6500459B1 (en) * 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine

Also Published As

Publication number Publication date
BRPI0413186A (pt) 2006-10-03
AR045193A1 (es) 2005-10-19
EP1651218A1 (fr) 2006-05-03
US20050065183A1 (en) 2005-03-24
RU2006105720A (ru) 2007-09-10
CR8220A (es) 2006-07-27
AU2004262914A1 (en) 2005-02-17
ZA200600519B (en) 2007-01-31
ECSP066327A (es) 2006-07-28
WO2005013987A1 (fr) 2005-02-17
JP2007500682A (ja) 2007-01-18

Similar Documents

Publication Publication Date Title
NO20060991L (no) Feksofenadinsammensetning og fremgangsmate til fremstilling
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
NO20100569L (no) Farmasoytiske formuleringer og anvendelse derav i forebyggelsen av slag, diabetes og/eller kongestivt hjertesvikt
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
NO20081889L (no) Fast vaksine formulering
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
WO1999033792A3 (fr) Promedicaments des inhibiteurs de l'aspartyl-transferase
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
TW200633694A (en) Composition and method for treating asthma
WO2003057150A3 (fr) Formulation pharmaceutique d'hydrochlorure stable et procédé de préparation
MX2023009833A (es) Formulaciones farmaceuticas de cetanafadina y metodos para prepararlas y utlizarlas.
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
SE0102440D0 (sv) New compound
DE60215129D1 (de) Esmolol-enthaltende zubereitungen
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
WO2005051350A3 (fr) Comprime dispersible dans l'eau